Defibrillator: Global Market Outlook

Mar 2023| MDS082A| BCC Publishing
Sample Report

Report Highlights

This report on defibrillators provides a brief description of the current status of the industry and recent developments. The report analyzes the market trends and rising opportunities in the developed and developing world.

Report Includes

  • A brief general outlook of the global market for defibrillators
  • Analysis of current and future market potential and discussion on the market drivers, challenges, and opportunities
  • Analyses of global market trends with data from 2019-2022, and projections of compound annual growth rates (CAGRs) through 2027
  • Segmentation of the defibrillators market by type, end use and region
  • Insight into the recent industry structure, regulations and policies, pipeline products, and the vendor landscape of the market leading participants

Report Scope

The rising prevalence of cardiovascular diseases (CVDs) due to changed lifestyles has fueled the market for defibrillators. Lifestyle diseases such as hypertension, obesity, type 2 diabetes, and dyslipidemia are the major risk factors for CVD. CVD prevalence is also increasing due to the growing geriatric population, so the incidence of heart disease is expected to increase. During the last few years, significant improvements have been made in defibrillators. The development of subcutaneous implantable cardioverter-defibrillator (S-ICDs) and cardiac resynchronization therapy defibrillators (CRT-Ds) is expected to drive market growth during the forecast period. High growth opportunities for defibrillators in emerging markets have also fueled the demand.

This report provides a brief exposure to the defibrillators global market. This report highlights the current and future market potential for this medical equipment and offers a brief analysis of the market's drivers, challenges, and opportunities. Revenues are broken down by region, type, and end user. For market estimates, data has been provided for 2019, 2020 and 2021 (as the base year), projections for 2022, and a forecast for 2027. The report also covers the market share for major market players. It includes the company profiles of the major players, with brief information about their business segments, financials, product portfolios, and recent developments. The report also provides an analysis of the impact of the COvID-19 pandemic on this market.

This report on defibrillators provides a brief description of the current status of the industry and recent developments. The report analyzes the market trends and identifies critical medical and geographical challenges and rising opportunities in the developed and developing world.

Frequently Asked Questions (FAQs)

The defibrillators market is projected to grow from $14.0 billion in 2021 to $22.4 billion in 2027, at a compound annual growth rate (CAGR) of 8.2 % during the forecast period.
The key factors driving the growth of the defibrillators market includes
  • Increasing prevalence of cardiovascular diseases
  • Technological advancements and innovations
  • Growing aging population specially in Asia-Pacific region
  • Increasing Government initiatives
  • Increase in use of AEDs in public places
The defibrillators market is segmented on the basis of type-Implantable Cardioverter Defibrillator and External Defibrillators and by region.
Implantable Cardioverter defibrillators will dominate the market by the end of 2027.
North America holds the highest share in the market.
Key companies in the market includes Medtronic PLC., Abbott Laboratories, Asahi Kasei Corporation, Philips Medical Corporation, Boston Scientific Corporation, and Stryker

Analyst Credentials

BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.

Report Synopsis

Report Metrics Details
Base year considered 2021
Forecast period considered 2022 to 2027
Base year market size $14.1 billion
Market size forecast $22.4 billion
Growth rate CAGR of 8.2% during the forecast period of 2022-2027
Units considered $ Millions
Segments covered By type, End-Use, and Region
Regions covered North America, Europe, Asia-Pacific, and Rest of the World (RoW)
Key Market Drivers
  • Increasing Prevalence of the Cardiac Disorders
  • Technological Advancements in Defibrillators
  • Growing Awareness and Government Initiatives
Companies studied
  • PHILIPS MEDICAL CORP.
  • ABBOTT LABORATORIES
  • ASAHI KASEI CORP.
  • BIOTRONIK SE & CO. KG
  • BOSTON SCIENTIFIC CORP.
  • DEFIBTECH LLC
  • LIVANOVA
  • MEDIANA
  • MEDTRONIC PLC
  • NIHON KOHDEN CORP.
  • STRYKER CORP.

Table of Contents & Pricing

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
. Title/Chapter NamePagesPrice Member Price
Full Report: Defibrillator: Global Market Outlook78 $3,500 Free
Defibrillator: Global Market Outlook

Single User License: $3500

Become a Member

Already a member? Login to access this report free.

Have a Question? Ask Us.

Why BCC Research.?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
Custom Research

Need a custom data table, graph or complete report? Tell us more.

RELATED REPORTS